News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
232,293 Results
Type
Article (5103)
Company Profile (24)
Press Release (227166)
Multimedia
Podcasts (2)
Webinars (4)
Section
Business (82325)
Career Advice (463)
Deals (15065)
Drug Delivery (8)
Drug Development (19083)
Employer Resources (30)
FDA (3691)
Job Trends (3912)
News (120291)
Policy (7524)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (295)
Accelerated approval (6)
Adcomms (4)
Allergies (14)
Alliances (14840)
ALS (38)
Alzheimer's disease (296)
Antibody-drug conjugate (ADC) (41)
Approvals (3791)
Artificial intelligence (83)
Autoimmune disease (27)
Automation (5)
Bankruptcy (98)
Best Places to Work (2867)
Biosimilars (32)
Biotechnology (23)
Bladder cancer (34)
Brain cancer (7)
Breast cancer (102)
Cancer (890)
Cardiovascular disease (61)
Career advice (395)
Career pathing (3)
CAR-T (64)
CDC (2)
Cell therapy (166)
Cervical cancer (5)
Clinical research (16693)
Collaboration (355)
Compensation (374)
Complete response letters (8)
COVID-19 (311)
CRISPR (13)
C-suite (340)
Cystic fibrosis (28)
Data (1331)
Denatured (1)
Depression (21)
Diabetes (79)
Diagnostics (2116)
Digital health (8)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (32)
Drug pricing (14)
Drug shortages (2)
Duchenne muscular dystrophy (37)
Earnings (42781)
Editorial (5)
Employer branding (6)
Employer resources (32)
Events (39182)
Executive appointments (426)
FDA (4432)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (343)
Gene editing (24)
Generative AI (6)
Gene therapy (104)
GLP-1 (145)
Government (423)
Guidances (197)
Healthcare (5059)
HIV (10)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (39)
Immuno-oncology (8)
Indications (16)
Infectious disease (337)
Inflammatory bowel disease (36)
Inflation Reduction Act (3)
Influenza (6)
Intellectual property (32)
Interviews (53)
IPO (7886)
IRA (3)
Job creations (1123)
Job search strategy (361)
JPM (4)
Kidney cancer (10)
Labor market (10)
Layoffs (106)
Leadership (5)
Legal (2338)
Liver cancer (21)
Longevity (2)
Lung cancer (96)
Lymphoma (70)
Machine learning (3)
Management (10)
Manufacturing (141)
MASH (50)
Medical device (3920)
Medtech (3930)
Mergers & acquisitions (7587)
Metabolic disorders (222)
Multiple sclerosis (18)
NASH (6)
Neurodegenerative disease (54)
Neuropsychiatric disorders (12)
Neuroscience (541)
NextGen: Class of 2026 (1674)
Non-profit (732)
Now hiring (5)
Obesity (91)
Opinion (32)
Ovarian cancer (26)
Pain (26)
Pancreatic cancer (38)
Parkinson's disease (50)
Partnered (7)
Patents (53)
Patient recruitment (98)
Peanut (6)
People (25237)
Pharmaceutical (7)
Pharmacy benefit managers (2)
Phase 1 (4998)
Phase 2 (7227)
Phase 3 (5791)
Pipeline (1980)
Policy (17)
Postmarket research (626)
Preclinical (1950)
Press Release (66)
Prostate cancer (57)
Psychedelics (3)
Radiopharmaceuticals (109)
Rare diseases (180)
Real estate (1886)
Recruiting (8)
Regulatory (5553)
Reports (17)
Research institute (309)
Resumes & cover letters (69)
Rett syndrome (19)
RNA editing (1)
RSV (2)
Schizophrenia (49)
Series A (53)
Series B (57)
Sickle cell disease (10)
Special edition (1)
Spinal muscular atrophy (33)
Sponsored (5)
Startups (1018)
Stomach cancer (1)
Supply chain (13)
Tariffs (7)
The Weekly (1)
Vaccines (80)
Venture capital (9)
Weight loss (30)
Women's health (6)
Date
Today (37)
Last 7 days (162)
Last 30 days (565)
Last 365 days (8927)
2026 (836)
2025 (9039)
2024 (11037)
2023 (13197)
2022 (18660)
2021 (19688)
2020 (18256)
2019 (13230)
2018 (10214)
2017 (10010)
2016 (9159)
2015 (12125)
2014 (9592)
2013 (7717)
2012 (8350)
2011 (8809)
2010 (8651)
Location
Africa (186)
Alabama (19)
Alaska (2)
Arizona (74)
Arkansas (1)
Asia (11789)
Australia (1693)
California (3549)
Canada (1141)
China (169)
Colorado (145)
Connecticut (163)
Delaware (70)
Europe (25501)
Florida (542)
Georgia (67)
Idaho (24)
Illinois (162)
India (16)
Indiana (106)
Iowa (9)
Japan (165)
Kansas (36)
Kentucky (17)
Louisiana (8)
Maine (51)
Maryland (352)
Massachusetts (2817)
Michigan (104)
Minnesota (202)
Mississippi (1)
Missouri (32)
Montana (17)
Nebraska (12)
Nevada (46)
New Hampshire (16)
New Jersey (1025)
New Mexico (5)
New York (817)
North Carolina (480)
North Dakota (4)
Northern California (1860)
Ohio (116)
Oklahoma (5)
Oregon (6)
Pennsylvania (598)
Puerto Rico (2)
Rhode Island (19)
South America (279)
South Carolina (17)
Southern California (1305)
Tennessee (61)
Texas (485)
United States (12374)
Utah (111)
Virginia (85)
Washington D.C. (17)
Washington State (297)
West Virginia (2)
Wisconsin (58)
Wyoming (1)
232,293 Results for "thermogenesis corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update
ThermoGenesis Holdings, Inc. reported financial and operating results for the third quarter ended September 30, 2023, and provided a corporate business update.
November 13, 2023
·
8 min read
Business
ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate Update
ThermoGenesis Holdings, Inc., a market leader in automated cell processing tools and services in the cell and gene therapy field, reported financial and operating results for the second quarter ended June 30, 2023, and provided a corporate business update.
August 10, 2023
·
8 min read
Business
ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update
ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the third quarter ended September 30, 2023, and provide a corporate strategic update on Thursday, November 13, 2023, after the close of trading.
November 8, 2023
·
3 min read
Business
ThermoGenesis Holdings Announces Year End 2022 Financial Results and Provides Corporate Update
ThermoGenesis Holdings, Inc. reported financial and operating results for the year ended December 31, 2022 and provided a corporate strategic update.
March 30, 2023
·
8 min read
Business
ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update
ThermoGenesis Holdings, Inc. announced that the Company will release its financial results for the second quarter ended June 30, 2023, and provide a corporate strategic update on Thursday, August 10, 2023, after the close of trading.
August 8, 2023
·
3 min read
Business
ThermoGenesis Holdings Announces First Quarter 2023 Financial Results and Provides Corporate Update
ThermoGenesis Holdings, Inc., a market leader in automated cell processing tools and services in the cell and gene therapy field, reported financial and operating results for the first quarter ended March 31, 2023 and provided a corporate strategic update.
May 15, 2023
·
8 min read
Business
ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide a Corporate Strategic Update
ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the first quarter ended March 31, 2023 and provide a corporate strategic update on Monday, May 15, 2023, after the close of trading.
May 10, 2023
·
3 min read
Business
ThermoGenesis Holdings to Announce Financial Results for the Year Ended December 31, 2022 and Provide a Corporate Strategic Update
ThermoGenesis Holdings, Inc. today announced that the Company will release its financial results for the year ended December 31, 2022 and provide a corporate strategic update on Thursday, March 30, 2023, after the close of trading. A conference call and webcast will follow at 1:30 p.m. PT/ 4:30 p.m. ET.
March 28, 2023
·
1 min read
Biotech Bay
ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference
ThermoGenesis Holdings, Inc. today announced that Chris Xu , Ph.D., Chief Executive Officer, will present a company overview on Wednesday, September 13, at 4:30 pm ET.
September 6, 2023
·
1 min read
Press Releases
Santhera Appoints Stifel as Corporate Finance Advisor
February 10, 2026
·
2 min read
1 of 23,230
Next
